share_log

Allmed Medical Products' (SZSE:002950) Shareholders Have More To Worry About Than Only Soft Earnings

Allmed Medical Products' (SZSE:002950) Shareholders Have More To Worry About Than Only Soft Earnings

Allmed Medical Products(深圳证券交易所:002950)股东要担心的不仅仅是收益疲软
Simply Wall St ·  2022/05/07 10:18

Allmed Medical Products Co., Ltd's (SZSE:002950) stock rose after its recent weak earnings report. Sometimes, shareholders are willing to ignore soft numbers with the hope that they will improve, but our analysis suggests this is unlikely for Allmed Medical Products.

Allmed 医疗用品有限公司 (SZSE: 002950) 股价在最近公布疲软的财报后上涨。有时,股东愿意忽视软数字,希望情况有所改善,但我们的分析表明,Allmed Medical Products不太可能出现这种情况。

See our latest analysis for Allmed Medical Products

查看我们对Allmed医疗产品的最新分析

SZSE:002950 Earnings and Revenue History May 7th 2022
深圳证券交易所:002950 收益和收入记录 2022 年 5 月 7 日

How Do Unusual Items Influence Profit?

不寻常的物品如何影响利润?

Importantly, our data indicates that Allmed Medical Products' profit received a boost of CN¥80m in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

重要的是,我们的数据表明,去年Allmed Medical Products的异常项目利润增加了8000万元人民币。我们不能否认,更高的利润通常使我们感到乐观,但如果利润是可持续的,我们更愿意这样做。我们统计了全球大多数上市公司的数字,在自然界中,一次性出现不寻常物品的情况很常见。而且,毕竟,这正是会计术语的含义。假设这些不寻常的项目在本年度不会再次出现,因此我们预计明年的利润将疲软(也就是说,在业务没有增长的情况下)。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Allmed Medical Products.

注意: 我们始终建议投资者检查资产负债表的实力。点击此处查看我们对Allmed Medical Products的资产负债表分析。

Our Take On Allmed Medical Products' Profit Performance

我们对Allmed医疗产品的利润表现的看法

Arguably, Allmed Medical Products' statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Allmed Medical Products' statutory profits are better than its underlying earnings power. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Allmed Medical Products, you'd also look into what risks it is currently facing. At Simply Wall St, we found 2 warning signs for Allmed Medical Products and we think they deserve your attention.

可以说,Allmed Medical Products的法定收入因不寻常的项目而被扭曲,从而提高了利润因此,我们认为Allmed Medical Products的法定利润可能优于其潜在的盈利能力。但好消息是,在过去三年中,其每股收益增长令人印象深刻。本文的目的是评估我们可以多大程度地依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。如果你想更深入地研究Allmed Medical Products,你还需要研究它目前面临的风险。在 Simply Wall St,我们发现了 Allmed Medical Products 的两个警告标志,我们认为它们值得你注意。

This note has only looked at a single factor that sheds light on the nature of Allmed Medical Products' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

本说明仅研究了揭示Allmed Medical Products利润性质的单一因素。但是,如果你能够将注意力集中在细节上,总会有更多值得发现的地方。例如,许多人认为高股本回报率表明商业经济状况良好,而另一些人则喜欢 “追随资金”,寻找内部人士正在购买的股票。所以你可能希望看到这个 免费的 一系列拥有高股本回报率的公司,或者这份内部人士正在买入的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发